These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6503814)

  • 1. Measles and subacute sclerosing panencephalitis. An argument for intensified vaccination in Australia.
    Robbins SJ
    Med J Aust; 1984 Sep; 141(6):325-7. PubMed ID: 6503814
    [No Abstract]   [Full Text] [Related]  

  • 2. A vaccine-preventable infectious disease kills half a million children annually.
    Katz SL
    J Infect Dis; 2005 Nov; 192(10):1679-80. PubMed ID: 16235162
    [No Abstract]   [Full Text] [Related]  

  • 3. Health impact of measles vaccination in the United States.
    Bloch AB; Orenstein WA; Stetler HC; Wassilak SG; Amler RW; Bart KJ; Kirby CD; Hinman AR
    Pediatrics; 1985 Oct; 76(4):524-32. PubMed ID: 3931045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Subacute sclerosing panencephalitis (SSPE) in Poland 1984-1986. Stage III of epidemiologic studies].
    Naruszewicz-Lesiuk D; Wieczorkiewicz M; Iwińska B; Kulczycki J; Gut W
    Przegl Epidemiol; 1988; 42(3):205-10. PubMed ID: 3254552
    [No Abstract]   [Full Text] [Related]  

  • 5. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized.
    Bellini WJ; Rota JS; Lowe LE; Katz RS; Dyken PR; Zaki SR; Shieh WJ; Rota PA
    J Infect Dis; 2005 Nov; 192(10):1686-93. PubMed ID: 16235165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subacute sclerosing panencephalitis in a tertiary care centre in post measles vaccination era.
    Sonia M; Lalit D; Shobha B; Sheffali G; Amandeep S; Veena K; Madhuri B
    J Commun Dis; 2009 Sep; 41(3):161-7. PubMed ID: 22010482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles vaccination and risk of SSPE.
    Agarwal RK
    Indian Pediatr; 1999 Mar; 36(3):317. PubMed ID: 10713848
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk of subacute sclerosing panencephalitis from measles vaccination.
    Halsey N
    Pediatr Infect Dis J; 1990 Nov; 9(11):857-8. PubMed ID: 2263442
    [No Abstract]   [Full Text] [Related]  

  • 9. Subacute sclerosing panencephalitis in children: prevalence in South China.
    Ip P; Chung BH; Wong VC; Chan KY
    Pediatr Neurol; 2004 Jul; 31(1):46-51. PubMed ID: 15246492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric Subacute Sclerosing Panencephalitis: A Narrative Review on Measles and the Future of Vaccination.
    Sulaiman SA; Vora NM; Chhabra K; Bashir MA; Awan Z
    J Child Neurol; 2024 Mar; 39(3-4):89-97. PubMed ID: 38477320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subacute sclerosing panencephalitis mortality, United States, 1979-2016: Vaccine-induced declines in SSPE deaths.
    Pallivathucal LB; Noymer A
    Vaccine; 2018 Aug; 36(35):5222-5225. PubMed ID: 30057285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subacute sclerosing panencephalitis in Wales.
    Sussman J; Compston DA
    Q J Med; 1994 Jan; 87(1):23-34. PubMed ID: 8140214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subacute sclerosing panencephalitis should be eliminated by measles vaccination.
    Liu WL; He ZX; Li F; He D; Ai R
    Hum Vaccin Immunother; 2017 Sep; 13(9):2038-2040. PubMed ID: 28750182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles, measles vaccination, and risk of subacute sclerosing panencephalitis (SSPE).
    Zilber N; Rannon L; Alter M; Kahana E
    Neurology; 1983 Dec; 33(12):1558-64. PubMed ID: 6685828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complications of measles and antimeasles vaccination].
    Reinert P; Lemerle S; Kohout G; Bernaudin F
    Ann Pediatr (Paris); 1984 Jun; 31(6):477-80. PubMed ID: 6147112
    [No Abstract]   [Full Text] [Related]  

  • 16. [Analysis of the correlation between measles and subacute sclerosis panencephalitis (SSPE) before and after introduction of vaccination in Poland].
    Gut W; Naruszewicz-Lesiuk D
    Przegl Epidemiol; 1992; 46(4):295-301. PubMed ID: 1305779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subacute Sclerosing Panencephalitis: The Foothold in Undervaccination.
    Holt RL; Kann D; Rassbach CE; Schwenk HT; Ritter JM; Rota PA; Elbers J
    J Pediatr; 2016 Dec; 179():259-262. PubMed ID: 27634625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reasons for vaccinating against measles].
    Celers J; Netter R
    Bull Acad Natl Med; 1982 Jun; 166(6):801-7. PubMed ID: 6756595
    [No Abstract]   [Full Text] [Related]  

  • 19. Measles, mumps, rubella vaccine induced subacute sclerosing panencephalitis.
    Belgamwar RB; Prasad S; Appaya P
    J Indian Med Assoc; 1997 Nov; 95(11):594. PubMed ID: 9567594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of the effect of measles vaccination on the epidemiology of SSPE.
    Campbell H; Andrews N; Brown KE; Miller E
    Int J Epidemiol; 2007 Dec; 36(6):1334-48. PubMed ID: 18037676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.